Free online session · hosted by Vera Platform
The deviation that can’t wait
Noise, or a signal?
How sponsors tell the difference, from EDC query to decision.
Which studies
Is your study a fit?
Studies where timely deviation review could change what happens next.
Examples
Eligibility-sensitive studies
A missed eligibility issue could lead to dosing an ineligible participant.
Time-critical therapies
Patient-specific treatments where manufacturing starts before a concern surfaces.
Higher-risk device studies
Implants and similar, where deviations call for robust review.
Not every study needs live review.The key question: could faster visibility change a decision, or the outcome of your study?
For sponsors, CROs and academic research teams
CRAs are welcome when invited by their sponsor or CRO.
The panel
One deviation. Four chairs.
Live simulation of how one deviation decision flows.
Four chairs, one honest question each.
The CRA
Where would you first have seen it?
Marija-Jasna Basic · Senior CRA, 15+ years in site monitoring · Founder, Monocytes
The CRO
Where did it go next, and why did it take 14 days?
Ina Burgstaller · 20 years as CRA and clinical project manager
The sponsor
When should you have known: before dosing, within 24 hours, or at the next review?
Kadifa Chambers · Clinical Operations · Founder, Clinical Research Mastermind
The auditor
Six months later, can you prove who knew what, and when?
Christoph Ortland · GCP auditor and trainer · Founder, Forschungsdock CRO
Cutting through the noise
The truth from the people who run trials. What nobody says in a meeting, said out loud.
- The CRA’s truth
Where a deviation like this is really first seen.
- The CRO’s truth
Where 14 days disappear between the site and the sponsor.
- The sponsor’s truth
When they actually needed to know, and what changes when they find out late.
- The auditor’s truth
Whether the emails, trackers and EDC together could prove who decided what, and when.
- Together
A shared rule of thumb: which studies need faster decisions, and which don’t.
The takeaway
Reviewing late isn’t the mistake.
Not knowing which study couldn’t wait is.
Register · free
Save your place in 30 seconds
Registration starts with one question. Your answer shapes what the panel discusses.
- 1Answer one question
- 2Add your details
- 3Get your confirmation and joining link
Questions
Before you register
Is this a sales demo?
No. It’s an honest panel of practitioners on one example deviation. Qualified teams can try the same flow in Vera Deviate afterwards, in their own role.
Does it cost anything?
No. The session is free.
Will it be recorded?
Registered participants receive a short summary afterwards. Join live if you want to ask about your own study.
Can I bring a colleague?
Yes. Ask them to register too, so they receive the joining link.
Who qualifies for access to Vera?
Sponsor and CRO teams with a running or planned study where deviation oversight matters, particularly with outsourced CRAs. We confirm with you after the session.
What does access to Vera include?
Two weeks of role-based access to a practice study in Vera Deviate: CRAs, CRO reviewers and sponsors each practise their own step, with role-based micro-learnings. A fictional study and example deviations only; no real study data.
I’m a CRA. Can I join?
Yes, when your sponsor or CRO invites you. Tick “I’m a CRA” when you register and add who invited you.